Skip to content

DXA Precision and Accuracy Comparison Study

DXA Precision and Accuracy Comparison Study

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01530477
Acronym
DXA P&A
Enrollment
82
Registered
2012-02-10
Start date
2012-01-31
Completion date
2012-12-31
Last updated
2016-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteopenia

Keywords

Bone mineral density, weight, body composition, DEXA, DXA

Brief summary

This study is being conducted to examine the performance of three common DXA machines (1) Lunar iDXA, (2) Lunar Prodigy and (3) Hologic Discovery A in measuring bone density and body fat.

Detailed description

For this study, two specific groups of volunteers will be recruited. In one group, the scan will measure bone density and in the other group the scan will measure fat. The groups will be broken into weight groups to determine which of the scanners the subject will be scanned on. Subjects will have the option to participate in either one or both groups.

Interventions

DEVICELunar Prodigy (GEHC)

Lunar Prodigy (GEHC) used to obtain Skeletal, and/or Body Composition measurements

DEVICELunar iDXA (GEHC)

Lunar iDXA (GEHC) used to obtain Skeletal, and/or Body Composition measurements

DEVICEDiscovery A (Hologic

Discovery A (Hologic) used to obtain Skeletal, and/or Body Composition measurements

Sponsors

GE Healthcare
Lead SponsorINDUSTRY

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SCREENING
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
20 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

1. Men and women \> 20 years old 2. Willing to provide consent 3. Falls into one of three weight categories, with minimum 30 subjects per category. * Less than 200 lbs. * 200 (inclusive) to less than 350 lbs. * 350 (inclusive) to less than 450 lbs. 4. Participate in only one weight category in either skeletal or body composition cohort, or both.

Exclusion criteria

1. Inability to remain still for the duration of the DXA scans as judged by study Investigator. 2. Un-removable internal / external scan artifacts e.g. plaster casts, metal rodding naso-gastric tubes, etc. 3. Females of childbearing potential\* with actual (confirmed by positive urine pregnancy test) or suspected (based on study Investigator evaluation despite a negative urine test) pregnancy. 4. Subject had already given consent to participate in any aspect of this study.

Design outcomes

Primary

MeasureTime frameDescription
Short Term Precision Comparison Across Three DXA DevicesLess than 6 monthsBMD precision will be reported across three DXA devices in major skeletal and body composition sites. The short-term precision was calculated as RMS-SD (root mean square standard deviation) over the mean for each cohort. The skeletal cohort will not have short-term precision value for body composition indexes due to the different region of measurement. The same will apply to the body composition cohort. As the result, the Skeletal & Body Composition cohort identified in participant flow and overall study summary will not have an analysis provided.

Countries

United States

Participant flow

Recruitment details

A total of 17 subjects consented for the Skeletal Cohort only. A total of 12 subjects consented for the Body Composition Cohort only. A total of 53 subjects consented to participate in both the Skeletal and Body Composition cohorts. Recruitment occurred at the primary site from January to December 2012.

Pre-assignment details

Subjects were able to consent and participate in one or both cohorts (Outcome Measure Reporting Groups: Skeletal and Body Composition). GE prematurely ended the study with 82 consented individuals but a total of 135 scans were acquired across the cohorts.

Participants by arm

ArmCount
Skeletal
Recruitment for each cohort will include approximately equal male/female split (no gender bias). Depending on the weight category, for each cohort, a minimum of 30 adult subjects will be measured on two of the three systems, and 60 will be measured on all three systems (total of evaluable 90 subjects). Subjects willing to participate in Skeletal & Body Composition are counted towards the 90 evaluable subject requirement of the protocol for the Skeletal Cohort.
17
Body Composition
Recruitment for each cohort will include approximately equal male/female split (no gender bias). Depending on the weight category, for each cohort, a minimum of 30 adult subjects will be measured on two of the three systems, and 60 will be measured on all three systems (total of evaluable 90 subjects). Subjects willing to participate in Skeletal & Body Composition are counted towards the 90 evaluable subject requirement of the protocol for the Body Composition Cohort.
12
Skeletal and Body Composition
Skeletal and Body Composition was not a cohort that was actively recruited to, it is a cohort for reporting purposes. Subjects were able to consent and enroll to both Skeletal and Body Composition cohorts and these subjects will be counted for under this joint cohort.
53
Total82

Baseline characteristics

CharacteristicTotalSkeletalBody CompositionSkeletal and Body Composition
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
82 Participants17 Participants12 Participants53 Participants
Sex: Female, Male
Female
39 Participants8 Participants6 Participants25 Participants
Sex: Female, Male
Male
43 Participants9 Participants6 Participants28 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 700 / 65
serious
Total, serious adverse events
0 / 700 / 65

Outcome results

Primary

Short Term Precision Comparison Across Three DXA Devices

BMD precision will be reported across three DXA devices in major skeletal and body composition sites. The short-term precision was calculated as RMS-SD (root mean square standard deviation) over the mean for each cohort. The skeletal cohort will not have short-term precision value for body composition indexes due to the different region of measurement. The same will apply to the body composition cohort. As the result, the Skeletal & Body Composition cohort identified in participant flow and overall study summary will not have an analysis provided.

Time frame: Less than 6 months

ArmMeasureGroupValue (NUMBER)
SkeletalShort Term Precision Comparison Across Three DXA DevicesDiscovery A Femural neck BMD2.1 Percentage of variance
SkeletalShort Term Precision Comparison Across Three DXA DevicesProdigy Total Body BMDNA Percentage of variance
SkeletalShort Term Precision Comparison Across Three DXA DevicesiDXA Femural neck BMD1.5 Percentage of variance
SkeletalShort Term Precision Comparison Across Three DXA DevicesDiscovery A Total Body BMDNA Percentage of variance
SkeletalShort Term Precision Comparison Across Three DXA DevicesiDXA Total Femur BMD0.8 Percentage of variance
SkeletalShort Term Precision Comparison Across Three DXA DevicesIDXA Trunk BMDNA Percentage of variance
SkeletalShort Term Precision Comparison Across Three DXA DevicesDiscovery A Spine BMD1.2 Percentage of variance
SkeletalShort Term Precision Comparison Across Three DXA DevicesProdigy Trunk BMDNA Percentage of variance
SkeletalShort Term Precision Comparison Across Three DXA DevicesProdigy Total Femur BMD0.8 Percentage of variance
SkeletalShort Term Precision Comparison Across Three DXA DevicesDiscovery A Trunk BMDNA Percentage of variance
SkeletalShort Term Precision Comparison Across Three DXA DevicesProdigy Femural neck BMD1.6 Percentage of variance
SkeletalShort Term Precision Comparison Across Three DXA DevicesiDXA Leg BMDNA Percentage of variance
SkeletalShort Term Precision Comparison Across Three DXA DevicesDiscovery A Total Femur BMD0.7 Percentage of variance
SkeletalShort Term Precision Comparison Across Three DXA DevicesProdigy Leg BMDNA Percentage of variance
SkeletalShort Term Precision Comparison Across Three DXA DevicesProdigy Spine BMD1.3 Percentage of variance
SkeletalShort Term Precision Comparison Across Three DXA DevicesDiscovery A Leg BMDNA Percentage of variance
SkeletalShort Term Precision Comparison Across Three DXA DevicesiDXA Total Body BMDNA Percentage of variance
SkeletalShort Term Precision Comparison Across Three DXA DevicesiDXA Spine BMD1.0 Percentage of variance
Body Composition OnlyShort Term Precision Comparison Across Three DXA DevicesiDXA Total Body BMD0.8 Percentage of variance
Body Composition OnlyShort Term Precision Comparison Across Three DXA DevicesProdigy Spine BMDNA Percentage of variance
Body Composition OnlyShort Term Precision Comparison Across Three DXA DevicesDiscovery A Spine BMDNA Percentage of variance
Body Composition OnlyShort Term Precision Comparison Across Three DXA DevicesiDXA Femural neck BMDNA Percentage of variance
Body Composition OnlyShort Term Precision Comparison Across Three DXA DevicesProdigy Femural neck BMDNA Percentage of variance
Body Composition OnlyShort Term Precision Comparison Across Three DXA DevicesDiscovery A Femural neck BMDNA Percentage of variance
Body Composition OnlyShort Term Precision Comparison Across Three DXA DevicesiDXA Total Femur BMDNA Percentage of variance
Body Composition OnlyShort Term Precision Comparison Across Three DXA DevicesProdigy Total Femur BMDNA Percentage of variance
Body Composition OnlyShort Term Precision Comparison Across Three DXA DevicesDiscovery A Total Femur BMDNA Percentage of variance
Body Composition OnlyShort Term Precision Comparison Across Three DXA DevicesiDXA Spine BMDNA Percentage of variance
Body Composition OnlyShort Term Precision Comparison Across Three DXA DevicesProdigy Total Body BMD0.9 Percentage of variance
Body Composition OnlyShort Term Precision Comparison Across Three DXA DevicesDiscovery A Total Body BMD1.9 Percentage of variance
Body Composition OnlyShort Term Precision Comparison Across Three DXA DevicesIDXA Trunk BMD1.0 Percentage of variance
Body Composition OnlyShort Term Precision Comparison Across Three DXA DevicesProdigy Trunk BMD1.2 Percentage of variance
Body Composition OnlyShort Term Precision Comparison Across Three DXA DevicesDiscovery A Trunk BMD5.8 Percentage of variance
Body Composition OnlyShort Term Precision Comparison Across Three DXA DevicesiDXA Leg BMD0.8 Percentage of variance
Body Composition OnlyShort Term Precision Comparison Across Three DXA DevicesProdigy Leg BMD1.3 Percentage of variance
Body Composition OnlyShort Term Precision Comparison Across Three DXA DevicesDiscovery A Leg BMD1.9 Percentage of variance

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026